ArticleACS omega2018

Live Cell Mass Accumulation Measurement Non-Invasively Predicts Carboplatin Sensitivity in Triple-Negative Breast Cancer Patient-Derived Xenografts.

Graeme F Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.